Skip to main content
OpenTrials
Completed

NCT Number: NCT03684408

Radiofrequency Chip for Localization of Non-Palpable Breast Lesions

The purpose of the project is to compare Radiofrequency identification device (RFID) localization technique with the current clinical standard wire localization technique. The Investigator's hypotheses is that the RFID localization technique is non-inferior to wire localization for breast lesions (tumors).

The study will be conducted in two parts. The purpose of Part A is for physician training with the RFID device. Nine subjects will undergo RFID and wire localization prior to breast lesion excision. This will allow the breast radiologists and surgeons to become comfortable with RFID device placement and retrieval. Additionally, the investigators will pilot the data collection surveys and chart review methodology to be used in Part B.

The purpose of Part B is to conduct a randomized clinical trial to assess whether RFID localization is non-inferior to wire localization for breast lesions. For this part, sixty subjects will be randomized to RFID (N=30) or wire localization (N=30) at time of enrollment. Surveys will be used to gather data from participants, radiologists, surgeons, and technologists/mammography nurses. A variety of data will be collected including, but not limited to, information on tumor size, location, depth; subject demographics; adequacy of tumor margins, re-excision rates, accuracy of wire or chip placement, and surgical complications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Tumor Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Missouri

Columbia, Missouri, 65212, United States

About this study

As part of standard of care, participants will receive: an ultrasound (US) or mammographic guided localization; excisional breast surgery; and a follow-up visit in breast surgery clinic.

As part of the research protocol, participants will receive a RFID chip for the localization procedure and complete surveys.

Part A of this project is for physician training to master the technique of RFID placement and retrieval. On the day of surgery prior to going to the operating room, all participants will have the RFID placed first to allow radiologists to become familiar with placement of the RFID localizer. Participants will then immediately undergo wire localization. Either ultrasound or mammogram guidance will be used for the localization at the discretion of the performing radiologist. Surgeons will use a reader to locate the RFID chip during surgery. The wire will be present in the event the area of concern cannot be adequately located with the reader. Participants, radiologists, surgeons, breast surgery and radiology staff will complete surveys.

Part B of this project is a prospective trial to examine safety, efficacy, operating room utilization patterns, and satisfaction with RFID versus wire localization. Participants will be stratified based on technique of localization (either US guidance or mammographic guidance). Participants will then be randomized to receive either the wire or RFID localization. There will be four visits: one pre-op breast surgery visit in which enrollment will occur, one radiology procedure visit for localization, one surgical visit, and one post-operative visit. This is the same number of visits as standard of care. Participants, radiologists, surgeons, breast surgery and radiology staff will complete surveys.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women requiring image guided pre-operative breast tumor localization

Exclusion criteria

  • Tumors deeper than 6 cm from the skin surface
  • More than one tumor requiring localization
  • Tumors requiring bracketing
  • Tumors requiring Magnetic Resonance Imaging localization
  • Inability to complete survey
  • Pregnancy

Treatment and study plan

RFID Localization

Device

The RFID and wire localization devices used in this study are FDA approved for the image guided localization of breast tumors prior to surgical excision. The two techniques for localization will be compared in this trial.

Wire Localization

Device

The RFID and wire localization devices used in this study are FDA approved for the image guided localization of breast tumors prior to surgical excision. The two techniques for localization will be compared in this trial.

RFID and Wire Localization

Device

Both RFID and the standard of care wire localization will be performed for physician training.

Primary outcomes

  1. Number of Participants With Successful Localization

    Time frame: From the date of localization through the date of surgery up to 4 weeks; data collected during Visit 3 at time of surgery

    Whether the surgeon was able to identify and remove the tumor

Secondary outcomes

  1. Surveys of Satisfaction: Participant

    Time frame: Data collected during date of localization at Visit 2, up to approximately one month from baseline visit

    Survey Question: "Compared to expected, how uncomfortable was the localization?"

    Scored on a scale of 1 to 5 with the best being 5

  2. Surveys of Satisfaction

    Time frame: Data collected at baseline during Visit 1

    Surveys of Radiology Nurse ease of scheduling the localization procedure.

    Scored on a scale of 1 to 5 with the best being 5

  3. Surveys of Satisfaction

    Time frame: Data collected during date of localization at Visit 2, up to approximately one month from baseline visit

    Surveys of radiologist satisfaction with the localization procedure.

    Scored on a scale of 1 to 5 with the best being 5

  4. Number of Participants With Tumor Incompletely Excised

    Time frame: Surgical resection specimen collected during Visit 3, at time of surgery

    Number of participants with positive margin on pathology

Sponsors and collaborators

Lead sponsor

University of Missouri-Columbia

Other

Collaborators

  • Health Beacons

Registry information

Official study title

Use of a Radiofrequency Chip for Localization of Non-Palpable Breast Lesions: A Comparison to Wire Localization

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Sep 25, 2018
Registry last updated
Aug 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.